Arzneiwerk AG VIDA (FRA:TLIK)

Market Cap	810.34K -19.8%
Revenue (ttm)	28.41K -66.9%
Net Income	-460.09K
EPS	-0.07
Shares Out	6.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	8.00 (6,153.85%)
Ex-Dividend Date	n/a

Volume	34
Open	0.1300
Previous Close	0.2880
Day's Range	0.1300 - 0.1300
52-Week Range	0.0005 - 0.5900
Beta	44.45
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 1, 2026

About Arzneiwerk AG VIDA

Arzneiwerk AG VIDA supplies pharmaceuticals for newly developed or rare medicines in Europe. It also provides medications for cancer, autoimmune deficiencies, and combination therapies of personalized medicine. In addition, the company is involved in operating pharmacy data center that focuses on health data analysis. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TLIK

Financial Performance

In 2025, Arzneiwerk AG VIDA's revenue was 68,539, a decrease of -66.91% compared to the previous year's 207,099. Losses were -563,826, -32.52% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error